NCI Pathway to Independence Award (K99/R00 Clinical Trial Required)
This NIH/NCI K99/R00 career award supports postdoctoral cancer researchers transitioning to independent faculty positions, with a clinical trial required. It is applied for through a host research …
- Deadline
- Oct 14, 2027
- Posted
- Jan 14, 2025
- Award amount
- Amount not specified
Don’t miss this deadline
We’ll email you before Oct 14, 2027 so you have time to apply.
In plain English
This NIH/NCI K99/R00 career award supports postdoctoral cancer researchers transitioning to independent faculty positions, with a clinical trial required. It is applied for through a host research or education institution but effectively targets individual early-career investigators; foreign organizations are not eligible. No award amount is specified. Applicants should confirm they meet the career-stage and eligibility criteria, which are specific.
AI-generated summary to help you decide quickly — verify the official eligibility rules before applying.
Who can apply
Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Organizations) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply.
About this grant
The purpose of the NCI Pathway to Independence Award (K99/R00) program is to facilitate a timely transition of talented postdoctoral researchers with a research and/or clinical doctorate degree from mentored, postdoctoral research positions to independent, tenure-track or equivalent faculty positions. The program will provide independent NCI research support during this transition in order to help awardees to launch competitive, independent research careers.
Let AI draft your application
Your first draft is free: a narrative and budget outline tailored to this grant, emailed to you. Drafts are written in a nightly batch, so it arrives by email later — not instantly on this page.
Application Kit — $49 one-time
Winner intelligence + a first-draft narrative grounded in applications that actually won. One payment, no subscription.
Get the Application Kit →Related grants
Other open grants funding Education and Health — soonest deadline first.
NIDA Mentored Clinical Scientist Development Program Award in Substance Use and Substance Use Disorder Research (K12 Clinical Trial Optional)
National Institutes of Health · Up to $750K · Due in 27 days
Secondary Analysis and Integration of Existing Data to Elucidate Cancer Risk and Related Outcomes (R21 Clinical Trials Not Allowed)
National Institutes of Health · Up to $200K · Due Nov 17, 2026
Ethical, Legal and Social Implications (ELSI) Research (R01 Clinical Trial Optional)
National Institutes of Health · Amount varies · Due Nov 18, 2026
Ethical, Legal and Social Implications (ELSI) Exploratory/Developmental Research Grant (R21 Clinical Trial Optional)
National Institutes of Health · Amount varies · Due Nov 18, 2026
Competing Revisions to Existing NIH Single Project Research Grants and Cooperative Agreements (Clinical Trial Optional)
National Institutes of Health · Amount varies · Due Nov 24, 2026
Emerging Global Leader Award (K43 Independent Clinical Trial Not Allowed)
National Institutes of Health · Amount varies · Due Dec 3, 2026
Also listed under National Institutes of Health, Education Grants and Health Grants.
Source: public records via Grants.gov. UseGrants is an independent aggregator, not affiliated with any funding agency. Always confirm details on the official listing before applying.